$ZION

MCLEAN SCOTT J sold 6,650 shares of ZION

MCLEAN SCOTT J (President) sold 6,650 shares of ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ (ZION) on 2026-07-28.

Original reporting
SEC EDGAR · MCLEAN SCOTT J
Published Jul 29, 2026, 8:55 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 29, 2026, 8:58 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ZION
Neutral
medium confidence
Mentioned
$ZION
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ZIONNeutralLow
01

Why it matters

Insider selling can be a mild sentiment input, but without transaction price, proceeds, or accompanying corporate news, it is unlikely to drive a durable repricing.

02

Market read

Traders may note the insider sale for sentiment monitoring, but the disclosure lacks the details needed for a high-conviction trade.

03

What to watch

No 10b5-1 plan is stated, but the absence of proceeds and price makes it hard to infer intent or magnitude versus typical insider activity.

Relevance 3/10Novelty 2/10Timing: after-hours SEC Form 4 filing (2026-07-29) for a 2026-07-28 sale

Background

The article is an SEC Form 4 insider transaction disclosure for Zions Bancorporation, filed 2026-07-29.

Company-level read

Ticker impact

$ZIONNeutralMedium confidence
Context

Form 4 shows Zions Bancorporation president McLean Scott J sold 6,650 shares in an open-market transaction dated 2026-07-28.

Expected impact

Likely minimal impact; any effect would be sentiment-driven and short-lived.

Evidence & confidence

The filing is a primary-source Form 4, but the article provides no price, proceeds, or linkage to company-specific events beyond the sale itself.

Market effects

No sector read-across; this is an individual insider transaction without disclosed company catalysts.

None indicated.

None indicated.

Counterpoint

The sale may be planned for liquidity or diversification and does not necessarily reflect negative views, especially since the price is not disclosed.

Key entities

  • Zions Bancorporation

    Subject of the Form 4 insider sale by its president.

  • MCLEAN SCOTT J

    President who sold 6,650 shares via open-market sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ZIONMed

Zions (ZION) Q3 2026 Earnings Call Transcript

Zions (ZION) reported Q3 2026 net interest margin at 3.23%, down from prior periods. Loans grew 3.7% annualized, deposits 8.8%. Adjusted pre-provision net revenue was $338M, up 2% QoQ. The company acquired a multifamily agency lending business, expecting $17M-$20M revenue in 2027. Wealth management and strategic products drive growth. Net interest income rose 1% QoQ to $684M, but margin declined due to higher deposit costs.

$ZIONMed

TD Cowen reiterates Hold rating on Zions Bancorp, $69 price target

TD Cowen maintained a Hold rating on Zions Bancorp with a $69 price target, implying a 298.8% upside from the Oct 19 close of $17.30. The bank's recent earnings missed expectations due to weaker net interest income and higher expenses, raising concerns about growth and execution risk. Loan growth guidance is modest, and the bank relies on net interest margin expansion for income.

$ZIONMed

DA Davidson raises Zions Bancorp stock price target on earnings beat

DA Davidson raised its price target for Zions Bancorp (ZION) to $80 from $79, citing an earnings beat driven by provision benefits. The bank reported core EPS of $1.73, exceeding forecasts. ZION trades at a P/E of 8.05 and PEG of 0.17. Six analysts revised earnings upwards. The bank projects 8%-12% net interest income growth. Q3 2026 EPS was $1.78, beating estimates, but revenue missed forecasts. Jefferies lowered its target to $75.

$ZIONMed

Jefferies cuts Zions Bancorp stock price target on NII miss

Jefferies reduced Zions Bancorp's (ZION) price target to $75 from $80, citing a net interest income (NII) miss, though it maintained a Buy rating. ZION reported core EPS of $1.77, beating estimates, but core pre-provision net revenue missed expectations. The stock has a P/E ratio of 8.05 and a PEG ratio of 0.19, suggesting undervaluation. ZION guided for 8-12% NII growth over the next 12 months and a mid-3% net interest margin by 2027.

$ZIONHighAI 8/10

Zions Bancorp NA (ZION) (Q3 2026) Earnings Call Highlights: Earnings Jump 20% as Deposits

Zions Bancorp (ZION) reported Q3 2026 earnings up 20%, driven by deposit growth. Net interest margin fell 4 basis points sequentially. Full-year 2026 operating leverage guidance was cut to 40-50 basis points. Loan growth outlook was reduced to 2-4% for Q3 2027, with caution on commercial real estate. Deposit costs are expected to rise to 2%. The company anticipates $17-20M revenue from the Basis acquisition in 2027. Share buybacks may increase, subject to regulatory approval.

$ZIONMed

Zions Bancorporation Q3 Earnings Improve

Zions Bancorporation reported Q3 2026 earnings per share rose 20% to $1.78, driven by improved credit quality. Net income increased to $262M from $221M YoY. Non-interest income and net interest income also grew, while total interest income declined slightly.